Manoj Khadka: Omega-3s and Cardiovascular Outcomes in Hemodialysis
Manoj Khadka, Resident Doctor at Patan Hospital, shared a post on LinkedIn, about recent article by Charmaine E. Lok et al., published in NEJM, adding:
“Pleased to share my journal abstract presentation reviewing the PISCES trial, published in NEJM (Nov 2025), which evaluated the impact of omega-3 fatty acid (fish oil) supplementation on cardiovascular events in patients undergoing maintenance hemodialysis.
The presentation focused on the study methodology, key findings, clinical implications, and future directions regarding the role of fish oil in cardiovascular risk reduction among dialysis patients.”
Title: Fish Oil Supplementation Reduces Cardiovascular Events in Hemodialysis Patient
Authors: Charmaine E. Lok, M.D., Michael Farkouh, M.D., Brenda R. Hemmelgarn, M.D., Ph.D., Louise M. Moist, M.D., Kevan R. Polkinghorne, M.B., Ch.B., Ph.D., George Tomlinson, Ph.D., Paul Tam, M.D., Marcello Tonelli, M.D. and Jacob A. Udell, M.D., M.P.H.
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy